IP Library Granted Patent US 9,278,071
Granted Patent B2
US 9,278,071 · App. 14/001,645 · Granted Mar 8, 2016

Organic compound nano-powder, method for producing the same and suspension

Inventors: Takahiro Tada (Funabashi, JP); Kazuhiro Kagami (Funabashi, JP); Shiro Yokota (Funabashi, JP)
Assignee: ACTIVUS PHARMA CO., LTD.
A61K9/1682A61K9/10A61K9/145A61K9/146A61K31/12A61K31/167A61K31/192A61K31/196A61K31/216A61K31/405A61K31/41A61K31/445A61K31/57A61K31/573A61K31/7048B02C23/18A61K9/0048
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,278,071
App. No.
14/001,645
Granted
Mar 8, 2016
Kind
B2
Abstract

An organic compound nano-powder comprising a granular organic compound with an average particle diameter of 500 nm or less and a 90%-diameter of less than 1500 nm and a carbohydrate compound comprising at least any one of a sugar and a sugar alcohol and with amount of 0.3 times or more by mass relative to amount of the organic compound, a method for producing the same, and a suspension having the organic compound dispersed in a liquid dispersion medium in which the organic compound is insoluble or poorly soluble.

Claims (13)

1. A method for producing an organic compound nano-powder comprising:

mixing a granular organic compound, a granular sugar compound comprising at least any one of a granular sugar and a granular sugar alcohol and with amount of 0.3 times or more by mass relative to amount of the organic compound, and liquid in which the organic compound is insoluble or poorly soluble in a kneader;

wet-milling the organic compound using the granular sugar compound as a grinding medium after the mixing so that an average particle diameter thereof becomes 500 nm or less and a 90%-diameter thereof becomes less than 1500 nm; and

wherein the wet-milling of the organic compound is carried out while kneading the mixture obtained after the mixing in a kneader.

2. The method for producing an organic compound nano-powder according to claim 1 , wherein the granular sugar compound is in an amount of 0.5 to 30 times by mass relative to amount of the organic compound.

3. The method for producing an organic compound nano-powder according to claim 1 , wherein the mixing is carried out with adding a physiologically acceptable polyol as liquid in which the organic compound is insoluble or poorly soluble.

4. The method for producing an organic compound nano-powder according to claim 1 , wherein a drying is carried out after the milling.

5. The method for producing an organic compound nano-powder according to claim 1 , wherein the granular sugar compound is one or more kinds selected from the group consisting of mannitol, maltitol, xylitol, erythritol, glucose, fructose, inositol, lactose, trehalose, cellobiose and dextrin.

6. The method for producing an organic compound nano-powder according to claim 1 , wherein a physiologically acceptable salt is further mixed in the process of the mixing.

7. The method for producing an organic compound nano-powder according to claim 6 , wherein the physiologically acceptable salt is sodium chloride.

8. The method for producing an organic compound nano-powder according to claim 1 , wherein the organic compound is one or more kinds selected from the group consisting of clarithromycin, fexofenadine hydrochloride, fluorometholone, curcuminoid, curcumin, rutin, mefenamic acid, acetaminophen, ibuprofen, amphotericin B, diclofenac sodium, indomethacin, felbinac, pranlukast hydrate, dexamethasone and fenofibrate.

9. The method for producing an organic compound nano-powder according to claim 1 , wherein the mass ratio of the granular sugar compound to the liquid is 1.75-to-1 or more.

10. The method for producing an organic compound nano-powder according to claim 1 , wherein the granular sugar compound comprises an average particle diameter of 10-631 microns.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 14, 2022
From: ACTIVUS PHARMA CO., LTD.
To: FORMOSA PHARMACEUTICALS, INC.
Reel/Frame 062087/0842 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 12, 2013
From: TADA, TAKAHIRO; KAGAMI, KAZUHIRO; YOKOTA, SHIRO
To: ACTIVUS PHARMA CO., LTD.
Reel/Frame 031192/0140 →
Priority Claims (1)
JP 2012-108972 · May 11, 2012 · national
Continuity (1)
Related Publication 20140328917A1 · Nov 6, 2014